Moneycontrol PRO

you are here: HomeNewsBusinessCompaniesSee 2% margin growth in FY14: Nectar Lifesciences

SHOW NAMES

Trending Topics

business

See 2% margin growth in FY14: Nectar Lifesciences

In an upbeat mood post the numbers, Aryan Goyal of Nectar Lifesciences is confident that the company would see robust numbers going ahead.

first published: May 16, 2013 01:54 pm

LATEST VIDEOS

A collection of the most-viewed Moneycontrol videos.

Meesho's Rs 5,421 Cr IPO Kicks Off| Post-IPO Playbook, Profitability Path & More| IPO Watch Live
Can Nifty Hold Above 26,000 Amid Currency Jitters? Meesho IPO Opens | Opening Bell Live
Nifty Struggles Below 26,100 On Weekly F&O Expiry As Rupee Hits New Low| Closing Bell Live
Will Rupee Slide & Expiry Day Caution Keep Nifty Bulls On The Back Foot? | Opening Bell Live

Watch and Follow our leading shows

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347